The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer
Curcio, C.; Brugiapaglia, S.; Bulfamante, S.; Follia, L.; Cappello, P.; Novelli, F. The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer. Molecules 2021, 26, 1642. https://doi.org/10.3390/molecules26061642
Curcio C, Brugiapaglia S, Bulfamante S, Follia L, Cappello P, Novelli F. The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer. Molecules. 2021; 26(6):1642. https://doi.org/10.3390/molecules26061642
Chicago/Turabian StyleCurcio, Claudia, Silvia Brugiapaglia, Sara Bulfamante, Laura Follia, Paola Cappello, and Francesco Novelli. 2021. "The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer" Molecules 26, no. 6: 1642. https://doi.org/10.3390/molecules26061642